NO161620C - Analogifremgangsm te for fremstilling av terapeutisk aktive 8-alkyltio-2-piperazino-pyrimido(5,4-d)pyrimidin-derivater. - Google Patents

Analogifremgangsm te for fremstilling av terapeutisk aktive 8-alkyltio-2-piperazino-pyrimido(5,4-d)pyrimidin-derivater.

Info

Publication number
NO161620C
NO161620C NO852514A NO852514A NO161620C NO 161620 C NO161620 C NO 161620C NO 852514 A NO852514 A NO 852514A NO 852514 A NO852514 A NO 852514A NO 161620 C NO161620 C NO 161620C
Authority
NO
Norway
Prior art keywords
group
acid addition
addition salts
compounds
alkyl group
Prior art date
Application number
NO852514A
Other languages
English (en)
Norwegian (no)
Other versions
NO161620B (no
NO852514L (no
Inventor
Josef Roch
Armin Heckel
Josef Nickl
Erich Mueller
Berthold Narr
Rainer Zimmermann
Johannes Weisenberger
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO852514L publication Critical patent/NO852514L/no
Publication of NO161620B publication Critical patent/NO161620B/no
Publication of NO161620C publication Critical patent/NO161620C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO852514A 1984-06-22 1985-06-21 Analogifremgangsm te for fremstilling av terapeutisk aktive 8-alkyltio-2-piperazino-pyrimido(5,4-d)pyrimidin-derivater. NO161620C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843423092 DE3423092A1 (de) 1984-06-22 1984-06-22 Neue 8-alkylthio-2-piperazino-pyrimido(5,4-d) pyrimidine, ihre herstellung und diese verbindungen enthaltende arzneimittel

Publications (3)

Publication Number Publication Date
NO852514L NO852514L (no) 1985-12-23
NO161620B NO161620B (no) 1989-05-29
NO161620C true NO161620C (no) 1989-09-06

Family

ID=6238919

Family Applications (1)

Application Number Title Priority Date Filing Date
NO852514A NO161620C (no) 1984-06-22 1985-06-21 Analogifremgangsm te for fremstilling av terapeutisk aktive 8-alkyltio-2-piperazino-pyrimido(5,4-d)pyrimidin-derivater.

Country Status (19)

Country Link
US (1) US4714698A (es)
EP (1) EP0167817B1 (es)
JP (1) JPH0694465B2 (es)
KR (1) KR920007435B1 (es)
AT (1) ATE46511T1 (es)
AU (1) AU579869B2 (es)
CA (1) CA1241325A (es)
DE (2) DE3423092A1 (es)
DK (1) DK282285A (es)
ES (1) ES8604590A1 (es)
FI (1) FI80455C (es)
GR (1) GR851467B (es)
IE (1) IE58432B1 (es)
IL (1) IL75596A0 (es)
NO (1) NO161620C (es)
NZ (1) NZ212515A (es)
PH (1) PH21319A (es)
PT (1) PT80670B (es)
ZA (1) ZA854683B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075594B2 (ja) * 1986-03-25 1995-01-25 三井石油化学工業株式会社 新規ピリドピリミジン誘導体
GB8719368D0 (en) * 1987-08-15 1987-09-23 Wellcome Found Heterocyclic compounds
US4885300A (en) * 1988-03-03 1989-12-05 Ortho Pharmaceutical Corporation 4-Substituted pyrazolo[3,4-D]pyrimidine derivatives
DE4325900A1 (de) * 1993-08-02 1995-02-09 Thomae Gmbh Dr K Trisubstituierte Pyrimido [5,4-d] pyrimidine zur Modulation der Multidrugresistenz, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
TW414798B (en) * 1994-09-07 2000-12-11 Thomae Gmbh Dr K Pyrimido (5,4-d) pyrimidines, medicaments comprising these compounds, their use and processes for their preparation
DE19608653A1 (de) * 1996-03-06 1997-09-11 Thomae Gmbh Dr K Pyrimido[5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
US7618975B2 (en) 2003-07-03 2009-11-17 Myriad Pharmaceuticals, Inc. 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
US8309562B2 (en) * 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
US8258145B2 (en) * 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
CA2592900A1 (en) 2005-01-03 2006-07-13 Myriad Genetics Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
ATE549338T1 (de) * 2006-05-24 2012-03-15 Boehringer Ingelheim Int Substituierte pteridine, die mit einem viergliedrigen heterocyclus substituiert sind

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1116676B (de) * 1955-03-14 1961-11-09 Thomae Gmbh Dr K Verfahren zur Herstellung von Pyrimido [5, 4-d] pyrimidinen
US3031450A (en) * 1959-04-30 1962-04-24 Thomae Gmbh Dr K Substituted pyrimido-[5, 4-d]-pyrimidines
US3322755A (en) * 1964-03-10 1967-05-30 Boehringer Sohn Ingelheim Basic-substituted 1, 2, 3, 4-tetrahydropyrimido [5, 4-d]-pyrimidines
GB1190419A (en) * 1966-08-16 1970-05-06 Yamanouchi Pharma Co Ltd Substituted Pyrimido-Pyrimidines and a process for the preparation thereof
DE3069211D1 (en) * 1979-07-03 1984-10-25 Thomae Gmbh Dr K 2-(perhydro-1,4-diazino)-pyrimido(5,4-d)pyrimidines, their preparation and medicaments containing them
DE2926804A1 (de) * 1979-07-03 1981-01-22 Thomae Gmbh Dr K Neue 2-(perhydro-1,4-diazino)-pyrimido- eckige klammer auf 5,4-d eckige klammer zu pyrimidine, deren herstellung und verwendung als arzneimittel
DE3049207A1 (de) * 1980-12-27 1982-07-29 Dr. Karl Thomae Gmbh, 7950 Biberach Neue trisubstituierte pyrimido (5,4-d) pyrimidine, ihre herstellung und ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
AU4396885A (en) 1986-01-02
PH21319A (en) 1987-09-28
ATE46511T1 (de) 1989-10-15
DE3423092A1 (de) 1986-01-02
DK282285D0 (da) 1985-06-21
ZA854683B (en) 1987-02-25
AU579869B2 (en) 1988-12-15
EP0167817B1 (de) 1989-09-20
ES8604590A1 (es) 1986-02-01
EP0167817A1 (de) 1986-01-15
IE851545L (en) 1985-12-22
FI852445L (fi) 1985-12-23
CA1241325A (en) 1988-08-30
FI852445A0 (fi) 1985-06-20
US4714698A (en) 1987-12-22
FI80455B (fi) 1990-02-28
GR851467B (es) 1985-11-25
PT80670B (de) 1987-05-08
JPS6115883A (ja) 1986-01-23
KR920007435B1 (ko) 1992-09-01
NO161620B (no) 1989-05-29
NZ212515A (en) 1988-10-28
KR860000287A (ko) 1986-01-27
IL75596A0 (en) 1985-10-31
ES544417A0 (es) 1986-02-01
DE3573119D1 (en) 1989-10-26
NO852514L (no) 1985-12-23
DK282285A (da) 1985-12-23
PT80670A (de) 1985-07-01
IE58432B1 (en) 1993-09-22
FI80455C (fi) 1990-06-11
JPH0694465B2 (ja) 1994-11-24

Similar Documents

Publication Publication Date Title
DE68925223D1 (de) 3-Alkenyl-1-azabicyclo(3.2.0)hept-2-en-2-carbonsäure-Verbindungen
NO161620C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 8-alkyltio-2-piperazino-pyrimido(5,4-d)pyrimidin-derivater.
IL75987A (en) Tri-and tetrasubstituted-1,4-dihydro-1,6-naphthyridine-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
NO871575D0 (no) Fremgangsmaate for fremstilling av 1,5-benztiazepinderivater.
ATE70838T1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
PL255643A1 (en) Method of obtaining 2-pyridinothiole derivatives
DE3764918D1 (de) 2,6-piperazin-dion-derivate, ihre verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
SE8804696D0 (sv) Dioxazocine derivatives their preparation and compositions containing them
ATE75468T1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.